Boston Therapeutics, Inc.

BTHE · OTC
Analyze with AI
9/30/2021
6/30/2021
3/31/2021
12/31/2020
Operating Activities
Net Income-$2,474-$4-$14-$0
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1$1$6-$0
Other Non-Cash$2,471$1$8$1
Operating Cash Flow-$4-$1-$0-$0
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$7$5$0$0
Financing Cash Flow$7$5$0$0
Forex Effect-$4$0$0$0
Net Chg. in Cash-$2$4$0-$0
Supplemental Information
Beg. Cash$4$0$0$0
End Cash$2$4$0$0
Free Cash Flow-$5-$1-$0-$0